Align Technology, Inc.
ALGNMedical Instruments & Supplies
$153.71+0.06%As of Oct 29vs prior close
- Market cap
- $10.9B
- P/E (TTM)
- 26.7×
- P/E (FY1)
- 13.7×
- From 52W high
- −22.18%
- EPS (LTM)
- $5.74
- Revenue (LTM)
- $4.1B
- Net margin
- 9.99%
- Dividend yield
- 0.00%
Nomior Score
63
Discounted QualityTop 20% of the scored universe
Growth35
Quality76
Value72
Momentum53
Resilience56
Growth
+15.77%revenue a year over 9 fiscal years
YE16 $1.1BLTM $4.1B
Connections
Revenue to profitQ3 YE26
13% of revenue became net profit, up 8 pts on a year.
Latest resultsThird Quarter 2026
- Revenue
- $1.015 billion
- Net income
- $135.0 million
- Diluted EPS
- $1.90
- Adjusted EPS
- $2.80
- Revenue outlook
- $1,000M to $1,020M
Clear Aligner revenue and volume grew year over year, while Imaging Systems and CAD/CAM Services revenue declined. Profitability improved from the prior year, though foreign exchange, higher fuel-related transportation costs and lower Clear Aligner pricing weighed on margins. Management described a challenging market backdrop and expects continued share repurchases in the coming quarter.
Who owns it
5funds, 1 tracked portfolio